journal article·2024-10Open access

Osteogenic‐Like Microenvironment of Renal Interstitium Induced by Osteomodulin Contributes to Randall's Plaque Formation

Zewu Zhu, Fang Huang, Meng Gao, Minghui Liu, Youjie Zhang, Liang Tang, Jian Wu, Hao Yu, Cheng He, Jinbo Chen, Zhongqing Yang, Zhiyong Chen, Yang Li, Hequn Chen, Ting Lei, Feng Zeng, Yu Cui

Advanced Science· Volume 11· Issue 40

Abstract

Abstract Calcium oxalate (CaOx) kidney stones are common and recurrent, lacking pharmacological prevention. Randall's plaques (RPs), calcium deposits in renal papillae, serve as niduses for some CaOx stones. This study explores the role of osteogenic‐like cells in RP formation resembling ossification. CaP crystals deposit around renal tubules, interstitium, and blood vessels in RP tissues. Human renal interstitial fibroblasts (hRIFs) exhibit the highest osteogenic‐like differentiation potential compared to chloride voltage‐gated channel Ka positive tubular epithelial cells, aquaporin 2 positive collecting duct cells, and vascular endothelial cells, echoing the upregulated osteogenic markers primarily in hRIFs within RP tissues. Utilizing RNA‐seq, osteomodulin (OMD) is found to be upregulated in hRIFs within RP tissues and hRIFs following osteogenic induction. Furthermore, OMD colocalizes with CaP crystals and calcium vesicles within RP tissues. OMD can enhance osteogenic‐like differentiation of hRIFs in vitro and in vivo. Additionally, crystal deposits are attenuated in mice with Omd deletion in renal interstitial fibroblasts following CaOx nephrocalcinosis induction. Mechanically, a positive feedback loop of OMD/BMP2/BMPR1A/RUNX2/OMD drives hRIFs to adopt osteogenic‐like fates, by which OMD induces osteogenic‐like microenvironment of renal interstitium to participate in RP formation. We identify OMD upregulation as a pathological feature of RP, paving the way for preventing CaOx stones.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Kidney Stones and Urolithiasis Treatments · Dermatological and Skeletal Disorders · Parathyroid Disorders and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Urology Xiangya Hospital Central South University Changsha Hunan 410008 China

National Clinical Research Center for Geriatric Disorders Xiangya Hospital Central South University Changsha Hunan 410008 China

Department of Internal Medicine Section Endocrinology Yale University School of Medicine New Haven CT 06519 USA

Department of Orthopedics Xiangya Hospital Central South University Changsha Hunan 410008 China

Department of Orthopaedic Surgery The First Affiliated Hospital School of Medicine Zhejiang University Hangzhou Zhejiang 310006 China

Funding

National Natural Science Foundation of China

References (73)

Show source-provided references
1. 10.3390/healthcare1103042410.3390/healthcare11030424 ↗
2. Fisang C. · Dtsch. Arztebl. Int. · 2015 · 112 · 83
3. 10.1111/bju.1617910.1111/bju.16179 ↗
4. 10.1681/ASN.201406063110.1681/ASN.2014060631 ↗
5. 10.1038/nrdp.2016.810.1038/nrdp.2016.8 ↗
6. 10.1097/00000658-193706000-0001410.1097/00000658-193706000-00014 ↗
7. 10.1007/s00240-014-0703-y10.1007/s00240-014-0703-y ↗
8. Chung H. J. · Transl. Androl. Urol. · 2014 · 3 · 251
9. 10.1021/acsnano.9b0766410.1021/acsnano.9b07664 ↗
10. 10.1016/j.juro.2011.10.12510.1016/j.juro.2011.10.125 ↗
11. 10.1111/j.1523-1755.2005.00388.x10.1111/j.1523-1755.2005.00388.x ↗
12. 10.1007/s00240-005-0488-010.1007/s00240-005-0488-0 ↗
13. 10.1002/ar.2058010.1002/ar.20580 ↗
14. 10.1186/s10020-022-00576-410.1186/s10020-022-00576-4 ↗
15. 10.2217/epi-2021-021210.2217/epi-2021-0212 ↗
16. 10.1038/sj.ki.500023810.1038/sj.ki.5000238 ↗
17. 10.1038/s41467-023-38975-810.1038/s41467-023-38975-8 ↗
18. 10.1038/s41420-019-0138-x10.1038/s41420-019-0138-x ↗
19. 10.1007/s00018-021-03972-x10.1007/s00018-021-03972-x ↗
20. 10.3892/ijmm.2021.498210.3892/ijmm.2021.4982 ↗
21. 10.1152/ajprenal.00035.201810.1152/ajprenal.00035.2018 ↗
22. 10.1016/j.juro.2016.04.08610.1016/j.juro.2016.04.086 ↗
23. 10.1007/s00240-014-0718-410.1007/s00240-014-0718-4 ↗
24. 10.1016/S0022-5347(17)61284-910.1016/S0022-5347(17)61284-9 ↗
25. 10.1002/ar.2327510.1002/ar.23275 ↗
26. 10.1002/med.100910.1002/med.1009 ↗
27. 10.1146/annurev-biochem-060815-01492210.1146/annurev-biochem-060815-014922 ↗
28. 10.1016/j.bbamcr.2024.11977110.1016/j.bbamcr.2024.119771 ↗
29. 10.1038/s41413-020-00115-z10.1038/s41413-020-00115-z ↗
30. 10.1002/jbmr.34810.1002/jbmr.348 ↗
31. 10.1002/jcp.2303210.1002/jcp.23032 ↗
32. 10.1093/nar/gkp33510.1093/nar/gkp335 ↗
33. 10.1093/nar/gkaa51610.1093/nar/gkaa516 ↗
34. 10.1093/nar/gkx110610.1093/nar/gkx1106 ↗
35. 10.1093/bioinformatics/btr06410.1093/bioinformatics/btr064 ↗
36. 10.1186/s13287-020-1562-910.1186/s13287-020-1562-9 ↗
37. 10.1096/fj.202100670RR10.1096/fj.202100670RR ↗
38. 10.3389/fmolb.2021.59331010.3389/fmolb.2021.593310 ↗
39. 10.1111/j.1464-410X.2009.08637.x10.1111/j.1464-410X.2009.08637.x ↗
40. 10.1016/S0022-5347(05)01017-710.1016/S0022-5347(05)01017-7 ↗
41. 10.1083/jcb.141.3.83910.1083/jcb.141.3.839 ↗
42. 10.1002/jcp.2301010.1002/jcp.23010 ↗
43. 10.1186/s12903-018-0680-610.1186/s12903-018-0680-6 ↗
44. 10.1038/s41419-021-03404-510.1038/s41419-021-03404-5 ↗
45. 10.1002/ctm2.68210.1002/ctm2.682 ↗
46. 10.1161/STROKEAHA.121.03722310.1161/STROKEAHA.121.037223 ↗
47. 10.1016/j.cytogfr.2009.10.01810.1016/j.cytogfr.2009.10.018 ↗
48. 10.1177/15440591040830070810.1177/154405910408300708 ↗
49. 10.1016/j.biomaterials.2020.12048410.1016/j.biomaterials.2020.120484 ↗
50. Hamaya E. · Int. J. Mol. Med. · 2019 · 44 · 2336
51. 10.1097/01.ju.0000120291.90839.4910.1097/01.ju.0000120291.90839.49 ↗
52. 10.1002/path.171107030810.1002/path.1711070308 ↗
53. 10.1038/s41581-020-00392-110.1038/s41581-020-00392-1 ↗
54. 10.1007/s00240-014-0704-x10.1007/s00240-014-0704-x ↗
55. 10.1038/s42003-018-0038-210.1038/s42003-018-0038-2 ↗
56. 10.1681/ASN.201511127110.1681/ASN.2015111271 ↗
57. 10.1016/j.bbrc.2007.07.19310.1016/j.bbrc.2007.07.193 ↗
58. 10.1016/j.cbi.2021.10960510.1016/j.cbi.2021.109605 ↗
59. 10.1155/2021/646328110.1155/2021/6463281 ↗
60. 10.1016/j.bbadis.2015.06.02010.1016/j.bbadis.2015.06.020 ↗
61. 10.1016/j.urology.2013.11.00410.1016/j.urology.2013.11.004 ↗
62. 10.2310/6650.2006.0602110.2310/6650.2006.06021 ↗
63. 10.1016/j.immuni.2023.12.00310.1016/j.immuni.2023.12.003 ↗
64. 10.1152/ajprenal.00243.201010.1152/ajprenal.00243.2010 ↗
65. 10.1016/j.ijsu.2016.11.01810.1016/j.ijsu.2016.11.018 ↗
66. 10.1172/JCI1703810.1172/JCI17038 ↗
67. 10.1161/CIRCULATIONAHA.123.06430110.1161/CIRCULATIONAHA.123.064301 ↗
68. 10.1161/CIRCRESAHA.118.31298110.1161/CIRCRESAHA.118.312981 ↗
69. 10.1038/ng.356810.1038/ng.3568 ↗
70. 10.3390/cancers1202025510.3390/cancers12020255 ↗
71. 10.1152/ajpcell.00462.201010.1152/ajpcell.00462.2010 ↗
72. 10.3389/fcell.2020.59636310.3389/fcell.2020.596363 ↗
73. 10.1016/j.ajpath.2019.07.01310.1016/j.ajpath.2019.07.013 ↗